K562
Showing 1 - 25 of 657
Follicular Lymphoma Trial in Boston (Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells)
Active, not recruiting
- Follicular Lymphoma
- Lethally Irradiated Lymphoma cells with GM-CSF K562 Cells
-
Boston, MassachusettsDana-Farber Cancer Institute
Feb 28, 2022
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome-Refractory Anemia With Excess Blasts Trial in
Completed
- Acute Myeloid Leukemia
- +2 more
- GM-K562/leukemia cell vaccine
-
Boston, MassachusettsDana-Farber Cancer Institute
Sep 15, 2020
Chronic Lymphocytic Leukemia Trial in Boston (GM-K562 vaccine, stem cell transplantation)
Completed
- Chronic Lymphocytic Leukemia
- GM-K562 vaccine
- stem cell transplantation
-
Boston, MassachusettsDana-Farber Cancer Institute
Sep 15, 2020
Leukemia Trial in Boston (GM-K562 cell vaccine, imatinib mesylate)
Completed
- Leukemia
- GM-K562 cell vaccine
- imatinib mesylate
-
Boston, MassachusettsDana Farber Cancer Institute
Oct 26, 2020
Sarcoma, Melanoma, Epithelial Malignancies Trial run by the NCI (Cyclophosphamide, Allogenic tumor Cell Vaccine (K562),
Terminated
- Sarcoma
- +3 more
- Cyclophosphamide
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2020
Lung Cancer, Esophageal Cancer, Malignant Pleural Mesothelioma Trial run by the NCI (Allogeneic Tumor Cell Vaccine (K562),
Terminated
- Lung Cancer
- +4 more
- Allogeneic Tumor Cell Vaccine (K562)
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2020
Healthy Volunteers Trial in Jackson (Immulina TM, Placebo)
Recruiting
- Healthy Volunteers
- Immulina TM
- Placebo
-
Jackson, MississippiUniversity of Mississippi Medical Center
Aug 23, 2022
MDS Trial in Baltimore (K562/GM-CSF cell vaccine)
Terminated
- Myelodysplastic Syndromes
- K562/GM-CSF cell vaccine
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Oct 18, 2018
Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,
Recruiting
- Hodgkin Disease
- +5 more
- MABEL CTLs
- +2 more
-
Houston, Texas
- +1 more
Jan 13, 2023
Upper Respiratory Infection Trial in Seoul (Allium Cepa L. Peel Heated Water Extract, Placebo)
Active, not recruiting
- Upper Respiratory Infection
- Allium Cepa L. Peel Heated Water Extract
- Placebo
-
Seoul, Korea, Republic ofHanyang University
Dec 27, 2022
Renal Dialysis, Hyperphosphatemia, Dietary Modification Trial in Ireland (Current Low Phosphorus Diet Prescription, Modified Low
Completed
- Renal Dialysis
- +2 more
- Current Low Phosphorus Diet Prescription
- Modified Low Phosphorus Diet Prescription
-
Tullamore, Offaly, Ireland
- +9 more
Jan 15, 2020
Leukemia Trial in Baltimore (GM-K562 cell vaccine, Interferon alfa, Sargramostim)
Completed
- Leukemia
- GM-K562 cell vaccine
- +2 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Oct 10, 2018
Acute Myeloid Leukemia Trial in Minsk (Expanded haploidentical NK cells)
Recruiting
- Acute Myeloid Leukemia
- Expanded haploidentical NK cells
-
Minsk, Minsk Region, BelarusBelarussian Research Center for Pediatric Oncology, Hematology a
Apr 12, 2022
Mild Cognitive Impairment Trial in Ottawa (Memory Support System)
Not yet recruiting
- Mild Cognitive Impairment
- Memory Support System
-
Ottawa, Ontario, CanadaBruyere Research Institute
Aug 10, 2023
Ulcerative Colitis Trial in Worldwide (PTG-100, Placebo)
Acute Myeloid Leukemia Trial in Minsk (NK cell infusions)
Recruiting
- Acute Myeloid Leukemia
- NK cell infusions
-
Minsk, Minsk Region, BelarusBelarussian Research Center for Pediatric Oncology, Hematology a
Feb 28, 2022
Hyperlipidemia Trial in Worldwide (Evolocumab, Placebo to Evolocumab)
Completed
- Hyperlipidemia
- Evolocumab
- Placebo to Evolocumab
-
Birmingham, Alabama
- +99 more
Jan 4, 2021
Leukemia, Acute Myeloid, Leukemia, Acute Lymphoblastic Trial in Minsk (Expanded Haploidentical Natural Killer cells, IL-2)
Completed
- Leukemia, Acute Myeloid
- Leukemia, Acute Lymphoblastic
- Expanded Haploidentical Natural Killer cells
- IL-2
-
Minsk, Minsk Region, BelarusBelarussian Research Center for Pediatric Oncology, Hematology a
Feb 28, 2022
Healthy Volunteers, Spinal Cord Injury, Stroke Trial in Manhasset (Transcutaneous Electrical Stimulation)
Recruiting
- Healthy Volunteers
- +5 more
- Transcutaneous Electrical Stimulation
-
Manhasset, New YorkNorthwell Health's The Feinstein Institute for Medical Research
Dec 28, 2022
Binge Eating Trial in San Antonio (Binge Eating Syndrome Treatment (BESTOW))
Recruiting
- Binge Eating
- Binge Eating Syndrome Treatment (BESTOW)
-
San Antonio, TexasThe University of Texas Health Science Center at San Antonio
Apr 6, 2023
Human Papillomavirus-Related Carcinoma, Human Papillomavirus Positive Oropharyngeal Carcinoma, Human Papillomavirus Positive
Active, not recruiting
- Human Papillomavirus-Related Carcinoma
- +5 more
- HPV Specific T Cells
- +3 more
-
Houston, TexasHouston Methodist Hospital
Jan 10, 2022
sCD62L and SPARC in Chronic Myeloid Leukemia Patients During
Completed
- Chronic Myeloid Leukemia
- ELISA kit
-
Tanta, EgyptTanta University
May 18, 2022
Multiple Sclerosis Trial in Ottawa (Lifestyle Physical Activity, General Wellness)
Recruiting
- Multiple Sclerosis
- Lifestyle Physical Activity
- General Wellness
-
Ottawa, Ontario, CanadaUniversity of Ottawa
Nov 23, 2022
Mild Cognitive Impairment Trial in Ottawa (Memory Support System)
Recruiting
- Mild Cognitive Impairment
- Memory Support System
-
Ottawa, Ontario, CanadaBruyere Research Institute
Apr 29, 2022